Pinson Charles Wright reports stock transaction for FB Financial
Pinson Charles Wright reports acquiring 319 shares of FB Financial Corp, increasing his ownership to 27,013 shares, reflecting confidence in the banking sector.
Stone Benjamin acquires 42,500 shares in biopharma firm
Stone Benjamin, Chief Business Officer at First Tracks Biotherapeutics, acquires 42,500 shares, reflecting executive compensation tied to performance metrics.
Moradi David sells over 150,000 shares of AudioEye Inc.
Moradi David reports the sale of over 150,000 shares of AudioEye Inc., reflecting changes in ownership that may impact investor sentiment.
FB Financial Corp director acquires shares in SEC filing
FB Financial Corp's director Orrin H. Ingram II acquired 319 shares at $54.97 each, reflecting the company's commitment to its compensation policy.
FB Financial Corp director acquires shares in stock transaction
FB Financial Corp's director William F. Carpenter III acquires 319 shares at $54.97 each, reflecting the company's compensation practices.
First Tracks Biotherapeutics CEO Acquires 136,000 Shares
First Tracks Biotherapeutics CEO Daniel Faga acquires 136,000 shares, reflecting alignment of executive compensation with shareholder interests.
Saba Capital Management Buys 200 Shares of Mexico Equity Fund
Saba Capital Management, L.P. reports purchase of 200 shares in Mexico Equity & Income Fund, signaling confidence in the financial sector.
First Tracks Biotherapeutics CFO Reports Stock Transaction
First Tracks Biotherapeutics CFO Ajim Tamboli reports a stock transaction, emphasizing performance-based incentives in executive compensation.
Newegg's Chief Legal Officer Reports Stock Transactions
Michael Chen of Newegg Commerce, Inc. disclosed stock transactions, including acquisitions and sales, reflecting executive adjustments in the retail sector.
Bigger Capital Fund boosts stake in ClearPoint Neuro to 5.33%
Bigger Capital Fund L P increases its stake in ClearPoint Neuro, Inc., now owning 5.33% of the company, signaling growing interest in the medical instruments sector.
Zoom CEO Eric S. Yuan Files to Sell 24,200 Shares
Eric S. Yuan, CEO of Zoom Communications, plans to sell 24,200 shares of Class A common stock as part of a pre-established selling plan.
Kubasik to Sell Shares of L3Harris Technologies
Christopher Kubasik files to sell over 5,000 shares of L3Harris Technologies, reflecting ongoing trends in executive stock transactions.
Kodiak Gas Services CEO McKee Files to Sell Shares
CEO Robert Michael McKee of Kodiak Gas Services files to sell shares as part of a pre-arranged trading plan, reflecting ongoing market activity.
Howard J. Siegel sells 2,000 shares of CME Group stock
Howard J. Siegel reports the sale of 2,000 shares of CME Group Inc., reducing his holdings to 19,873 shares as of November 2, 2026.
Chad Michael Whalen reports stock transactions at F5, Inc.
Chad Michael Whalen disclosed significant stock transactions at F5, Inc., highlighting his commitment to the company and the tech sector.
Redden Forrest Richard III Discloses Ownership in Colony Bankcorp
Redden Forrest Richard III reports share ownership in Colony Bankcorp Inc, indicating his active role as a director in the state commercial banking sector.
Indelicarto Thomas C reports sale of 500 Verisign shares
Indelicarto Thomas C, EVP at Verisign, sells 500 shares of common stock, reflecting ongoing insider trading activity in the tech industry.
Neurocrine CEO Gano Kyle Reports Stock Transactions
Gano Kyle, CEO of Neurocrine Biosciences, reports stock transactions, acquiring shares through restricted stock units as part of executive compensation.
Local Bounti's Interim CFO Reports Share Transaction
Local Bounti's interim CFO, Anthony Hughes, reports a transaction of 9,587 shares, highlighting ongoing leadership adjustments in the agricultural sector.
Local Bounti's General Counsel Reports Share Transaction
Local Bounti's General Counsel Margaret McCandless reports a transaction of 3,833 shares of common stock to cover tax liabilities from restricted stock units.